Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $5.5 million.

  • Journey Medical's Non-cash Items fell 4797.77% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 4797.77%. This contributed to the annual value of $6.2 billion for FY2024, which is 7993.99% up from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Non-cash Items is $5.5 million, which was down 4797.77% from $14.7 million recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Non-cash Items peaked at $9.7 billion during Q4 2021, and registered a low of $1.6 million during Q1 2023.
  • For the 5-year period, Journey Medical's Non-cash Items averaged around $1.3 billion, with its median value being $8.5 million (2022).
  • Per our database at Business Quant, Journey Medical's Non-cash Items skyrocketed by 12166712.06% in 2021 and then crashed by 8182.64% in 2023.
  • Over the past 5 years, Journey Medical's Non-cash Items (Quarter) stood at $9.7 billion in 2021, then tumbled by 77.04% to $2.2 billion in 2022, then skyrocketed by 55.16% to $3.4 billion in 2023, then soared by 79.94% to $6.2 billion in 2024, then tumbled by 99.91% to $5.5 million in 2025.
  • Its Non-cash Items stands at $5.5 million for Q3 2025, versus $14.7 million for Q2 2025 and $10.9 million for Q1 2025.